Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-04-11

FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (SA3, LLC)

View source ↗

Summary

FDA approved a supplemental application for cyclobenzaprine hydrochloride (SA3, LLC), indicating approval of a supplemental submission for an existing generic p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOBENZAPRINE HYDROCHLORIDE (Cyclobenzaprine hydrochloride)

Snippet

SUPPL AP for CYCLOBENZAPRINE HYDROCHLORIDE (CYCLOBENZAPRINE HYDROCHLORIDE)